SNX5 antibody (e.g., Proteintech 17918-1-AP) is a polyclonal rabbit IgG antibody targeting the SNX5 protein, which plays roles in endosomal sorting, actin remodeling, and antigen presentation. Key properties include:
| Property | Detail |
|---|---|
| Target | SNX5 (sorting nexin 5) |
| Host Species | Rabbit |
| Reactivity | Human, mouse, rat |
| Molecular Weight | ~47 kDa (observed) |
| Applications | WB, IP, IHC, ELISA |
| Immunogen | SNX5 fusion protein (Ag12330) |
| Storage | -20°C in PBS with 0.02% sodium azide and 50% glycerol |
| UniProt ID | Q9Y5X3 |
This antibody has been validated in diverse samples, including HEK-293T cells, kidney tissues, and immune cells like Jurkat and K-562 .
SNX5 regulates actin dynamics and lysosomal trafficking in B cells, critical for immune synapse formation and antigen extraction :
Membrane remodeling: SNX5 localizes to plasma membrane ruffles in resting B cells, facilitating antigen screening. Upon activation with immobilized antigens, SNX5 accumulates at the immune synapse to promote actin-dependent spreading .
Lysosomal integrity: SNX5-silenced B cells exhibit enlarged lysosomes, impairing antigen extraction and presentation .
Retromer complex: SNX5 interacts with retromer components to retrieve cargo from endosomes to the Golgi, affecting B-cell activation and antibody production .
SNX5 promotes tumor growth and therapy resistance in head and neck squamous cell carcinoma (HNSCC):
Tumor progression: SNX5 knockdown reduces colony formation in soft agar assays and decreases tumor volume in xenograft models .
NOTCH1 signaling: SNX5 stabilizes cleaved NOTCH1 and modulates Mcl-1 expression, enhancing cell survival .
SNX5 is essential for macropinosome biogenesis in primary macrophages, enabling efficient uptake and processing of soluble antigens (e.g., ovalbumin) .
SNX5 depletion disrupts lysosomal recruitment to synaptic membranes, reducing antigen extraction by 60% in B cells .
In macrophages, SNX5 loss decreases macropinosome formation by 70%, impairing soluble antigen processing .
High SNX5 expression correlates with poor prognosis in HNSCC .
SNX5 knockdown reduces cleaved NOTCH1 levels by 40%, sensitizing cells to apoptosis .
This antibody has been cited in 13+ publications, including studies on: